Burcon NutraScience Corporation
BU.TO · TSX
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | CA$0 | CA$0 | CA$0 | CA$0 |
| - Cash | CA$0 | CA$0 | CA$0 | CA$0 |
| + Debt | CA$0 | CA$0 | CA$0 | CA$0 |
| Enterprise Value | CA$0 | CA$0 | CA$0 | CA$0 |
| Revenue | CA$0 | CA$0 | CA$0 | CA$0 |
| % Growth | 4.4% | 699% | -30.4% | – |
| Gross Profit | -CA$0 | -CA$0 | -CA$0 | -CA$0 |
| % Margin | -680.2% | -419.2% | -1,283.5% | -367.3% |
| EBITDA | -CA$0 | -CA$0 | -CA$0 | -CA$0 |
| % Margin | -584.8% | -704.1% | -4,416.9% | -2,795.9% |
| Net Income | -CA$0 | -CA$0 | -CA$0 | -CA$0 |
| % Margin | -1,005.9% | -1,015.5% | -5,268.8% | -2,901.1% |
| EPS Diluted | -0.28 | -0.27 | -0.23 | -0.006 |
| % Growth | -3.7% | -17.4% | -3,609.7% | – |
| Operating Cash Flow | -CA$0 | -CA$0 | -CA$0 | -CA$0 |
| Capital Expenditures | -CA$0 | -CA$0 | -CA$0 | -CA$0 |
| Free Cash Flow | -CA$0 | -CA$0 | -CA$0 | -CA$0 |